Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 27 April 2022
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 27 April 2022. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share (excluding Revaluation Surplus) was Tk. 74.03 as on March 31, 2022 and Tk. 71.79 as on June 31, 2021. NAV per share (including Revaluation Surplus) was Tk. 81.96 as on March 31, 2022 and Tk. 79.76 as on June 31, 2021. (end)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
(ORIONPHARM-এর ধারাবাহিক খবর): শেয়ার প্রতি একত্রিত NAV (পুনর্মূল্যায়ন উদ্বৃত্ত ব্যতীত) ছিল টাকা। 31 মার্চ, 2022 অনুযায়ী 74.03 এবং টাকা 31 জুন, 2021 তারিখে 71.79। শেয়ার প্রতি NAV (পুনর্মূল্যায়ন উদ্বৃত্ত সহ) ছিল টাকা। 81.96 মার্চ 31, 2022 এবং টাকা 31 জুন, 2021 তারিখে 79.76। (শেষ)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6268c345cf6229bc6ab9b4f6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.